Is an atherogenic lipoprotein profile in the fetus a prerequisite for placental vascular disease?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 4, 2000, Pages 508-513

  Wang, Jian ^a   Trudinger, Brian ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; UMBILICAL VEIN;

ADULT; APOLIPOPROTEINS A; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; FEMALE; FETAL BLOOD; HUMANS; PLACENTAL INSUFFICIENCY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; ULTRASONOGRAPHY, PRENATAL; UMBILICAL CORD; VASCULAR DISEASES;

EID: 0034061126     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13270.x     Document Type: Article

References (30)

1. Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 1995; 76: 69 C-77 C.
2. Stampfer MJ, Krauss RM, Ma J et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882–888.
3. Assmann G, von Eckhardstein A, Funke H. High density lipoprotein, reverse transport of cholesterol, and coronary artery disease. Insights from mutations. Circulation 1993; 87: III28–III34.
4. Forte TM, McCall MR. The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. Curr Opin Lipidol 1994; 5: 354–364.
5. Sniderman AD. Apolipoprotein B, A-I as predictors of coronary artery disease. Can J Cardiol 1988; 4: 24A–30A.
6. Vaisanen S, Gavert J, Julkunen A, Voutilainen E, Penttila I. Correlation between the ratio of serum low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with that of serum apolipoproteins B, A-I. Int J Clin Lab Res 1993; 23: 160–164.
7. Lamarche B, Moorjani S, Lupien PJ et al. Apolipoprotein A-I, B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996; 94: 273–278.
8. Trudinger BJ, Cook CM. Doppler umbilical and uterine flow waveforms in severe pregnancy hypertension. Br J Obstet Gynaecol 1990; 97: 142–148.
9. Trudinger BJ, Cook CM, Giles WB et al. Fetal umbilical artery velocity waveforms and subsequent neonatal outcome. Br J Obstet Gynaecol 1991; 98: 378–384.
10. Hanretty KP, Primrose MH, Neilson JP, Whittle MJ. Pregnancy screening by Doppler uteroplacental and umbilical artery waveforms. Br J Obstet Gynaecol 1998; 96: 1163–1167.
11. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R, editors. Maternal fetal medicine: principles and practice. Philadelphia: WB Saunders, 1993.
12. Salafia CM. Placental pathology of fetal growth restriction. Clin Obstet Gynecol 1997; 40: 740–749.
13. Giles WB, Trudinger BJ, Beird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985; 92: 31–38.
14. Wilcox GR, Trudinger BJ. Fetal platelet consumption: a feature of placental insufficiency. Obstet Gynecol 1991; 77: 616–621.
15. Rogers BB, Bloom SL, Leveno KJ. Atherosis revisited: current concepts on the pathophysiology of implantation site disorder. Obstet Gynecol Surv 1999; 54: 189–195.
16. Barker DJ. Intrauterine programming of coronary heart disease and stroke. Acta Paediatr Suppl 1997; 423: 178–182; discussion 183.
17. Martyn CN, Barker DJ, Jespersen S, Greenwald S, Osmond C, Berry C. Growth in utero, adult blood pressure, and arterial compliance. Br Heart J 1995; 73: 116–121.
18. Martyn CN, Hales CN, Barker DJ, Jespersen S. Fetal growth and hyperinsulinaemia in adult life [In Process of Citation]. Diabet Med 1998; 15: 688–694.
19. Phillips K, Barker DJ, Hales CN, Fall CH, Osmond C, Clark PM. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993; 36: 225–228.
20. Barker DJ, Meade TW, Fall CH et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 1992; 304: 148–152.
21. Martyn CN, Meade TW, Stirling Y, Barker DJ. Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intrauterine growth. Br J Haematol 1995; 89: 142–146.
22. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. BMJ 1993; 307: 1524–1527.
23. Thompson RS, Trudinger BJ, Cook CM, Giles WB. Umbilical artery velocity waveforms. Normal reference values for AB ratio and Pourcelot ratio. Br J Obstet Gynaecol 1988; 95: 589–591.
24. Wang XL, Dudman NP, Blades BL, Wilken DE. Changes in the immunoreactivity of Apo A-I during storage. Clin Chim Acta 1989; 179: 285–293.
25. Wang XL, Dudman NP, Wilken DE. Enzyme-linked immunosorbent assay of apolipoprotein B in blood spotted onto filter paper, suitable for neonatal screening. Clin Chem 1989; 35: 1000–1004.
26. Spencer JA, Chang TC, Crook D et al. Third trimester fetal growth and measures of carbohydrate and lipid metabolism in umbilical venous blood at term. Arch Dis Child Fetal Neonatal Ed 1997; 76: F21–F25.
27. Srinivasan SR, Berenson GS. Serum apolipoproteins A-I, B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study. Clin Chem 1995; 41: 159–164.
28. Trudinger BJ, Cook CM, Giles WB, Connelly A, Thompson RS. Umbilical artery flow velocity waveforms in high-risk pregnancy. Randomised controlled trial. Lancet 1987; 1: 188–190.
29. Burke G, Stuart B, Crowley P, Scanaill SN, Drumm J. Is intrauterine growth retardation with normal umbilical artery blood flow a benign condition BMJ 1990; 300: 1044–1045.
30. Morlese JF, Jahoor F, Forrester TE. Plasma apolipoprotein A1 and birthweight [letter]. Lancet 1997; 350: 1823–1824.